Drugs / FOLFOX chemotherapy regimen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT05815082 Comparator | Feb 2023 → Feb 2031 expected | metastasis from malignant tumor of colon | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
| Phase 3 | NCT05797077 Background | Feb 2023 → Feb 2029 expected | cancer-related condition, metastasis from malignant tumor of colon | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOLFOX chemotherapy regimen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05815082 ↗ |